ProFESS trial: any lessons to learn for future anti-platelet trials?

Abstract

Secondary stroke prevention is a challenge, and there is continual pursuit to investigate the best antiplatelet therapy for patients. Therapy with aspirin following stroke reduced recurrent strokes and non-stroke-related mortality, possibly by lowering risk of cardiovascular events (1). However, the reduction is modest, with a relative risk reduction of 13… (More)
DOI: 10.1111/j.1747-4949.2009.00382.x

Topics

1 Figure or Table

Cite this paper

@article{Sharma2009ProFESSTA, title={ProFESS trial: any lessons to learn for future anti-platelet trials?}, author={Jagdish Chandra Sharma and Michael Vassallo and Ian N Ross}, journal={International journal of stroke : official journal of the International Stroke Society}, year={2009}, volume={4 6}, pages={458-60} }